Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

The Business Matrix: Tuesday 4 February 2014

 

Tuesday 04 February 2014 01:00 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Profits disappoint as Future falters

Future, the publisher of technology and entertainment magazines including T3 and Total Film, saw its share price tumble almost 8 per cent after it warned profits would come in at the “lower end” of forecasts. Group turnover rose 1 per cent, helped by a 9 per cent rise in digital. But advertising took a hit before Christmas as brands delayed campaigns.

Rexam drops pill and bottle arms

Packaging and can maker Rexam is offloading two healthcare businesses, making items like pill and medicine bottles, to a private equity firm for $805m (£489m), with plans to return the cash to shareholders. Investors will get £450m from the sale of Pharmaceutical Devices and Prescription Retail Packaging to Montague Private Equity.

Firms more likely to go bust in 2013

Retailers falling into administration in the last 12 months were less likely to survive than a year earlier, according to restructurer FRP Advisory. Around 20 retailers went bust in 2013, including HMV, with just 35 per cent of the stores saved, compared with 50 per cent in 2012. Staff survival rates were just 3 per cent in the final quarter of 2013.

Russian giant set to float in London

Russia’s second-biggest hypermarket group, Lenta, is poised to float on the London Stock Exchange in a listing that could value the business at more than £3bn and net the owners at least £600m. The flotation is expected to take place next month. The business is the latest in a long line of retailers heading for the stock market, including Poundland.

Alitalia to secure funding package

Alitalia is about to finalise loan agreements with banks for up to €200m pledged last year to help keep the Italian airline flying while it finds a new partner, its chief executive said. The loans are part of a €500m package to support the trouble airline while it finalises talks with Etihad Airways on a possible investment.

Citigroup sends in the cavalry to UK

Citigroup has appointed one of its top corporate bankers to head its British operations, where he will be manage the relationships with UK regulators and government. James Bardrick joined Citi in 1987 and took charge of corporate and investment banking for Europe, Middle East and Africa four years ago.

Spirits chief bets on African growth

Former Whyte & Mackay whisky boss Vivian Imerman, has bought a controlling stake in South African spirits firm TNB for 200m rand, aiming to tap the African middle class’s taste for alcohol. He was once dubbed “The Man from Del Monte” after turning the fruit company around.

Consolidation to reshape industry

The legal world is about to be reshaped by an M&A rush, a top industry dealmaker has warned. Sir Nigel Knowles – who turned DLA Piper into the world’s largest law firm – said consolidation “is an imminent certainty” and will happen “on a scale not previously witnessed”.

ArthroCare is sold for $1.7bn

Artificial hip and knee maker Smith & Nephew has paid $1.7bn for the medical device maker ArthroCare, just weeks after the US firm settled a long-running Department of Justice investigation into securities fraud at the company.

Manufacturing to slow, experts say

China’s manufacturing sector slowed down in January as experts braced themselves for a weaker performance this year. The country’s purchasing managers index eased to 50.5 in January from December’s 51 reading. The 50 mark signal stagnation.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in